Trends and geographical variation in invasive pneumococcal infections in Finland

References

• Fedson DS, Musher DM. Pneumococcal polysaccharide vaccine. Vaccines4th edn, SA Plotkin, WA Orenstein. WB Saunders Company, Philadelphia 2003; 529–88
   Google Scholar
• Robinson KA, Baughman W, Rothrock G, Barrett NL, Pass M, Lexau C, et al. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995–1998. Opportunities for prevention in the conjugate vaccine era. JAMA 2001; 285: 1729–35
   PubMed Web of Science ®Google Scholar
• Hausdorff WP, Siber G, Paradiso PR. Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children. Lancet 2001; 357: 950–2
   PubMed Web of Science ®Google Scholar
• Schonheyder HC, Sorensen HT, Kristensen B, Korsager B. Reasons for increase in pneumococcal bacteraemia. Lancet 1997; 349: 1554
   PubMed Web of Science ®Google Scholar
• Normark BH, Kalin M, Ortqvist A, Akerlund T, Liljequist BO, Hedlund J, et al. Dynamics of penicillin-susceptible clones in invasive pneumococcal disease. J Infect Dis 2001; 184: 861–9
   PubMed Web of Science ®Google Scholar
• Butler JC, Schuchat A. Epidemiology of pneumococcal infections in the elderly. Drugs Aging 1999; 15: 11–9
   PubMed Web of Science ®Google Scholar
• Nuorti JP, Butler JC, Gelling L, Kool JL, Reingold AL, Vugia DJ. Epidemiological relation between HIV and invasive pneumococcal disease in San Francisco County, California. Ann Intern Med 2000; 132: 182–90
   PubMed Web of Science ®Google Scholar
• Smith MD, Stuart J, Andrews NJ, Brunton WAT, Cartwright KAV. Invasive pneumococcal infection in south and west England. Epidemiol Infect 1998; 120: 117–23
   PubMed Web of Science ®Google Scholar
• Ihekweazu CA, Dance DA, Pebody R, George RC, Smith MD, Waight P, , et al. Trends in incidence of pneumococcal disease before introduction of conjugate vaccine: south-west England, 1996 − 2005. Epidemiol Infect 2008;136:1096–102.
   PubMed Web of Science ®Google Scholar
• Mumford RS. Sepsis, severe sepsis and septic shock. Principles and practice of infectious diseases6th edn, GL Mandel, JE Bennett, R Dolin. Elsevier Churchill Livingstone, Philadelphia 2005; 906–25
   Google Scholar
• Kilpi T, Herva E, Kaijalainen T, Syrjanen R, Takala AK. Bacteriology of acute otitis media in a cohort of Finnish children followed for the first 2 y of life. Pediatr Infect Dis J 2001; 20: 654–62
   PubMed Web of Science ®Google Scholar
• Agresti A. Poisson regression for rates. Categorical data analysis2nd edn. Wiley-Interscience, Holboken 2002; 385–7
   Google Scholar
• Laurichesse H, Romaszko JP, Nguyen LT, Souweine B, Poirier V, Guelon D, et al. Clinical characteristics and outcome of patients with invasive pneumococcal disease, Puy-de-Dome, France, 1994–1998. Eur J Clin Microbiol Infect Dis 2001; 20: 299–308
   PubMed Web of Science ®Google Scholar
• Hedlund J, Svenson SB, Kalin M, Henrichsen J, Olssonliljequist B, Mollerberg G, et al. Incidence, capsular types, and antibiotic susceptibility of invasive Streptococcus pneumoniae in Sweden. Clin Infect Dis 1995; 21: 948–53
   PubMed Web of Science ®Google Scholar
• Zangwill KM, Vadheim CM, Vannier AM, Hemenway LS, Greenberg DP, Ward JI. Epidemiology of invasive pneumococcal disease in Southern California: implications for the design and conduct of a pneumococcal conjugate vaccine efficacy trial. J Infect Dis 1996; 174: 752–9
   PubMed Web of Science ®Google Scholar
• Sankilampi U, Herva E, Haikala R, Liimatainen O, Renkonen OV, Leinonen M. Epidemiology of invasive Streptococcus pneumoniae infections in adults in Finland. Epidemiol Infect 1997; 118: 7–15
   PubMed Web of Science ®Google Scholar
• Konradsen HB, Kaltoft MS. Invasive pneumococcal infections in Denmark from 1995 to 1999: epidemiology, serotypes, and resistance. Clin Diagn Lab Immunol 2002; 9: 358–65
   PubMedGoogle Scholar
• Talbot TR, Poehling KA, Hartert TV, Arbogast PG, Halasa NB, Edwards KM, et al. Seasonality of invasive pneumococcal disease: temporal relation to documented influenza and respiratory syncytial viral circulation. Am J Med 2005; 118: 285–91
   PubMed Web of Science ®Google Scholar
• Stanek RJ, Mufson MA. A 20-y epidemiological study of pneumococcal meningitis. Clin Infect Dis 1999; 28: 1265–72
   PubMed Web of Science ®Google Scholar
• Kyaw MH, Clarke S, Jones IG, Campbell H. Incidence of invasive pneumococcal disease in Scotland, 1988–99. Epidemiol Infect 2002; 128: 139–47
   PubMed Web of Science ®Google Scholar
• Nielsen SV, Henrichsen J. Incidence of invasive pneumococcal disease and distribution of capsular types of pneumococci in Denmark, 1989–94. Epidemiol Infect 1996; 117: 411–6
   PubMed Web of Science ®Google Scholar
• Dahl MS, Trollfors B, Claesson BA, Brandberg LL, Rosengren A. Invasive pneumococcal infections in south-western Sweden: a second follow-up period of 15 y. Scand J Infect Dis 2001; 33: 667–72
   PubMedGoogle Scholar
• Pedersen MK, Hoiby EA, Froholm LO, Hasseltvedt V, Lermark G, Caugant DA. Systemic pneumococcal disease in Norway 1995–2001: capsular serotypes and antimicrobial resistance. Epidemiol Infect 2004; 132: 167–75
   PubMed Web of Science ®Google Scholar
• Breiman RF, Spika JS, Navarro VJ, Darden PM, Darby CP. Pneumococcal bacteraemia in Charleston County, South Carolina. A decade later. Arch Intern Med 1990; 150: 1401–5
   PubMedGoogle Scholar
• Skogberg K, Lyytikainen O, Ruutu P, Ollgren J, Nuorti JP. Increase in bloodstream infections in Finland, 1995 − 2002. Epidemiol Infect 2008 136 2008:108–14.
   PubMed Web of Science ®Google Scholar
• Ruutu P, Kuusi M, Nuorti PJ, Koskinen S. Communicable diseases. Health and functional capacity in Finland. Baseline results of the Health 2000 examination survey, A Aromaa, S Koskinen. National Public Health Institute, Helsinki 2040; 67–9
   Google Scholar
• Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003; 348: 1737–46
   PubMed Web of Science ®Google Scholar